What interaction occurs between hydrocodone and diflucan (fluconazole)?

Significant Drug Interaction: Fluconazole Increases Hydrocodone Levels and Effects

Fluconazole (Diflucan) can significantly increase hydrocodone plasma concentrations through inhibition of CYP3A4 and CYP2C19 enzymes, potentially leading to enhanced opioid effects including respiratory depression, excessive sedation, and increased risk of overdose. 1

Mechanism of Interaction

Fluconazole is a moderate CYP3A4 inhibitor and strong CYP2C19 inhibitor 1. Hydrocodone is metabolized primarily through these cytochrome P450 pathways 2. When fluconazole blocks these metabolic enzymes, hydrocodone accumulates in the bloodstream, resulting in:

• Elevated hydrocodone plasma concentrations
• Prolonged opioid half-life
• Intensified analgesic and sedative effects
• Increased risk of opioid toxicity

Clinical Significance and Risks

The FDA drug label explicitly warns that fluconazole inhibits CYP3A4-mediated metabolism of multiple drugs, and patients on narrow therapeutic window medications should be monitored for adverse reactions 1. While hydrocodone is not specifically listed in the contraindications, the general warning applies given hydrocodone's metabolism profile.

Critical risks include:

• Respiratory depression (documented with methadone-fluconazole interaction 3)
• Excessive sedation and drowsiness
• Confusion or altered mental status
• Increased risk of falls, particularly in elderly patients
• Potential for opioid overdose with standard hydrocodone doses

The enzyme-inhibiting effect of fluconazole persists 4-5 days after discontinuation due to its long half-life 1, meaning the interaction risk continues even after stopping fluconazole.

Management Recommendations

If this combination cannot be avoided:

1. Reduce hydrocodone dose by 25-50% when initiating fluconazole, particularly if fluconazole dose is ≥200 mg daily 1

2. Monitor closely for opioid toxicity during the first 4-5 days:

   • Respiratory rate (watch for <12 breaths/minute)
   • Level of sedation
   • Mental status changes
   • Oxygen saturation

3. Educate patients about signs of opioid overdose:

   • Extreme drowsiness or difficulty staying awake
   • Slow or shallow breathing
   • Confusion or unresponsiveness

4. Consider alternative antifungal agents with less CYP3A4 inhibition if clinically appropriate, though most azoles share this interaction risk 4

5. Avoid benzodiazepines during this combination, as fluconazole also increases benzodiazepine levels, compounding respiratory depression risk 1

Route-Specific Considerations

The interaction is more pronounced with oral fluconazole than intravenous administration for drugs with significant first-pass metabolism 5. Since hydrocodone is only available orally (combined with acetaminophen or ibuprofen) 6, 2, and fluconazole is commonly given orally, this represents a worst-case scenario for drug interaction magnitude.

Common Pitfalls

• Underestimating interaction severity: The fluconazole-opioid interaction is well-documented with methadone causing fatal respiratory depression 3; hydrocodone carries similar risk
• Forgetting the prolonged effect: Continuing standard hydrocodone doses immediately after stopping fluconazole (interaction persists 4-5 days) 1
• Missing acetaminophen toxicity: Hydrocodone combinations contain acetaminophen (max 325 mg per dose unit); monitor total daily acetaminophen from all sources 6
• Ignoring dose-dependency: Fluconazole doses <200 mg daily have less interaction potential, but monitoring remains essential 1

The safest approach is to use an alternative antifungal or alternative analgesic when possible, or implement aggressive dose reduction and monitoring protocols when the combination is medically necessary.